Protocol To Evaluate Patient Measurements After Ultrasonic Treatment (NCT01260298) | Clinical Trial Compass
CompletedNot Applicable
Protocol To Evaluate Patient Measurements After Ultrasonic Treatment
United States12 participantsStarted 2010-12
Plain-language summary
The objective of this study is to observe body contour changes following treatment using the MC1 device.
Who can participate
Age range20 Years – 50 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Is female.
✓. Is between 20 and 50 years of age, inclusive, on the day of enrolment.
✓. Has a BMI between 20 and 30 kg/m2.
✓. Is to be treated in the infra-scapular area using the MC1.
✓. Has never been treated with the MC1 before.
Exclusion criteria
✕. Patient is lactating, has a positive pregnancy test within 7 days of planned study procedure (for female patients of child-bearing potential), or intends to become pregnant during the study or is not using effective methods to prevent pregnancy.
✕. Currently enrolled in another device or drug study that has not completed the required follow-up period, or has completed all other study-required follow-up less than 30 days before enrolment in this study.
✕. Keloid scars, hypertrophic scars or a history of abnormal healing.